长期活跃多发性硬化症中的淋巴细胞-微细胞-细胞轴
Martina Absinta1,2,3, Dragan Maric4, Marjan Gharagozloo5
1Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. mabsint1@jhmi.edu.
Nature
|September 9, 2021
概括
多发性硬化 (MS) 病变的慢性脱髓化包括持续的神经退行. 针对补充成分1q (C1q) 为这种白质炎症提供了潜在的治疗策略.
科学领域:
- 神经免疫学
- 神经退化
- 磁共振成像 (MRI)
背景情况:
- 持续性多发性硬化 (MS) 病变表现为持续的脱髓化和轴突退化.
- 在MRI上显示的偏磁边缘病变表明多发性硬化不治病变具有活跃病理.
研究的目的:
- 阐明MS病变中慢性神经退行的机制.
- 确定进展性多发性硬化症的新疗法目标.
主要方法:
- 慢性多发性硬化病变边缘的MRI引导单核RNA测序.
- 质细胞和免疫细胞的转录概况.
- 在小鼠模型 (实验性自身免疫脑膜炎) 和人类多发性硬化组织中进行体内验证.
主要成果:
- 鉴定不同的质表型:"在MS中炎症的小质" (MIMS) 和"在MS中炎症的星球细胞".
- 在其他神经退行性疾病中,MIMS与微质具有相同的转录特征.
- 补充成分1q (C1q) 被确定为MIMS激活的关键介质.
结论:
- 多发性硬化和其他神经退行性疾病之间的共享机制表明了共同的治疗目标.
- 在多发性硬化中,抑制C1q是一种潜在的治疗策略.
- 偏磁边缘损伤作为监测C1q阻塞治疗反应的生物标志物.
相关概念视频
Glial Cells
Overview
T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...


